U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403071) titled 'Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research' on Feb. 04.
Brief Summary: The goal of this study is to find out if taking fish oil by mouth can help prevent or lessen a side effect called peripheral neuropathy in patients who are being treated with the chemotherapy drug bortezomib.
We are mainly looking to answer one question: Can fish oil reduce the chances of getting this nerve damage, or make it less severe, for these patients?
Study Start Date: May 01, 2026
Study Type: OBSERVATIONAL
Condition:
Multiple Myeloma
Periphera...